β2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk

Nav

General Info

Geography

Sweden (SWE)

Coverage type

Country

Time period covered

01/2007 - 12/2013

Data type

Scientific literature

Keywords

Parkinson's disease

Citation

Authors

Liu B, Svenningsson P, Ludvigsson JF, Lundholm C, Wallin J, Larsson H, Sjölander A, Williams DM, Pedersen NL, Wirdefeldt K

Journal

Ann Neurol

Volume

Issue

Pages

1023-1028

Publication year

2023

Suggested citation

Liu B, Svenningsson P, Ludvigsson JF, Lundholm C, Wallin J, Larsson H, Sjölander A, Williams DM, Pedersen NL, Wirdefeldt K. β2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk. Ann Neurol. 2023; 93(5): 1023-1028.

DOI

10.1002/ana.26638

PMID

36897287

GHDx Entry last modified on: Dec 12, 2023

Header sites

Search form

Main menu

β2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk

Nav